TX-FLUENCE
26.5.2020 12:02:04 CEST | Business Wire | Press release
Fluence by OSRAM (Fluence) has been selected by Wageningen University & Research (WUR) as the lighting provider for Serre Red, the university’s new, high-tech quarantine greenhouse. Serre Red will be used for critical research on plant diseases—caused by viruses, bacteria, fungi and parasitic nematodes—including quarantine pathogens, as well as research on genetically modified organisms.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200526005096/en/
Built by Bosman van Zaal, Serre Red is one of the most advanced quarantine research facilities constructed to date. It features 63 compartments, ranging from 15 to 52 square meters with individual climate control, air filtering and access locks. Extensive technical equipment has been installed in a corridor sunk below ground level to avoid excess shade. Other features of the fully electric greenhouse include insulated double glazing, external shading, heat/cold storage and autoclaving, which sterilizes all materials including water and waste before leaving the greenhouse.
Broad spectrum lighting: Choosing LED over HPS
To reduce the influence of artificial light on their experiments, WUR’s researchers required broad spectrum lighting. Unifarm, the university’s greenhouse and field research facility, ran a market consultation during November and December 2019, then selected four manufacturers from a tender in January 2020. Fluence was granted the order in April after the four potential solutions were examined by WUR’s scientific committee.
“Traditionally, our greenhouses are equipped with HPS lighting,” said Dolf Straathof, head of Unifarm. “As we want to eliminate any influences that artificial lighting could have on experiments, we looked for a solution that came closest to the spectrum that our scientific team specified as optimal.”
“Fluence was one of those consulted, and they proposed higher light levels than we initially specified, which concurred with recommendations from our researchers,” Straathof continued. “The PhysioSpec® solution that Fluence proposed also fit our spectral requirements. In the end, Fluence offered us the best possible solution and exceeded our requirements for uniformity, offering the highest uniformity for a mix of low and tall crops throughout all compartments.”
Optimizing light levels and uniformity
Each compartment will have individual lighting controls, linked to the Hoogendoorn climate control system.
“This is the first time WUR has chosen LED, and specifically broad spectrum LED, as their standard lighting solution for a research greenhouse at Unifarm,” said Theo Tekstra, Fluence’s technical director in Europe, the Middle East and Africa and lead for the project’s design and implementation. “LED solutions have the added advantage that they can be controlled without change in spectrum or loss of efficiency, offering constant light levels and optimal daily light integral. By using our compact VYPR 2x2 full spectrum LED fixtures with the new compact PSU drivers and VYPR reflectors, we minimize shading and optimize overall uniformity. We are extremely proud that our solution was selected as the best in the tender and that we were awarded the contract for this prestigious project.”
Critical research for the world’s growers
Fluence supports, sponsors and collaborates on horticultural research projects throughout the world, including its membership in the Wageningen Research Club of 100—part of the WUR Business Unit for Greenhouse Horticulture in Bleiswijk.
The spread of viral infections—such as the tomato brown rugose fruit virus (ToBRFV)—remains a top concern for growers throughout the world. The new Serre Red facility enables WUR to expand and intensify its research capabilities, maintaining its position as a world leader in research on horticultural crop pathogens.
“ToBRFV currently threatens tomato, bell pepper and chili pepper crops throughout the globe, causing most production greenhouses to close to visitors and creating increased costs for growers through extensive disinfection and other precautionary measures,” said Dr. Theoharis Ouzounis, horticultural scientist at Fluence. “There is no treatment other than prevention and pervasive damage has been reported globally. Research into prevention and treatment of viral diseases is extremely important to safeguard our food production.”
For more information about Fluence lighting solutions, visit www.fluence.science .
About Fluence by OSRAM
Fluence Bioengineering, Inc., a wholly-owned subsidiary of OSRAM , creates the most powerful and energy-efficient LED lighting solutions for commercial crop production and research applications. Fluence is a leading LED lighting supplier and is committed to enabling more efficient crop production with the world’s top vertical farms and greenhouse produce growers. Fluence global headquarters are based in Austin, Texas, with its EMEA headquarters in Rotterdam, The Netherlands. For more information about Fluence, visit www.fluence.science .
Link to high resolution pictures: www.fluence.science/press-links
View source version on businesswire.com: https://www.businesswire.com/news/home/20200526005096/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
Galderma Tackles Menopause-related Skin Changes With Global Survey and Clinical Trial Inclusivity30.1.2026 07:00:00 CET | Press release
Results from a global survey of over 4,300 women across five continents presented at IMCAS 2026 reveal a knowledge gap on the impact of menopause on the skin, despite women experiencing around three skin changes during menopause1 Galderma will also host a symposium delving into the challenges and science behind menopause-related skin changes and aesthetic solutions at the congress Galderma is committed to raising awareness of the impact of menopause on the skin, fostering meaningful dialogue between patients and healthcare professionals, and advancing science-backed solutions by incorporating menopausal status into all injectable aesthetics clinical trials Galderma (SIX: GALD) has unveiled findings from a global survey of peri- and post-menopausal women from nine countries exploring the impact of menopause on the skin at the International Master Course on Aging Science (IMCAS) 2026 World Congress in Paris, France, from January 29-31, 2026. The survey found that over 50% of women learne
Andersen Consulting styrker sine cybersikkerhedskompetencer med tilføjelsen af RedLegg30.1.2026 00:18:00 CET | Pressemeddelelse
Andersen Consulting styrker sit cybersikkerhedsudbud gennem en samarbejdsaftale med RedLegg, der er et cybersikkerhedsfirma med speciale i administreret trusselsdetektion og rådgivningsydelser. RedLegg blev grundlagt i 2008 og har hovedsæde i USA. RedLegg tilbyder skræddersyede cybersikkerhedsløsninger med fokus på risikominimering, administrerede sikkerhedstjenester og penetrationstest. Virksomhedens ydelser omfatter blandt andet managed detection and response (MDR), hændelsesrespons, udvikling af sikkerhedspolitikker samt virtuel CISO-rådgivning. RedLegg betjener mellemstore virksomheder inden for finans, forsikring, jura og sundhedssektoren og kombinerer automatisering, trusselsintelligens og et dedikeret Security Operations Center (SOC) for at hjælpe organisationer med at effektivisere deres cybersikkerhedsoperationer og opbygge langsigtet modstandsdygtighed. "Vores fokus har altid været at hjælpe kunder med at skære støjen fra og prioritere det, der virkelig betyder noget – nemlig
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
